Çѱ¹Á¦¾àÀÇ ±â¼ú¼±ÁøÈ­¸¦ À§ÇØ ²÷ÀÓ¾øÀÌ ¿¬±¸³ë·ÂÇϰí ÀÖ½À´Ï´Ù.
SHINPOONG PHARM.CO.,LTD.

ÆÄÀÌÇÁ¶óÀÎ

ºñÀÓ»ó ÀÓ»ó1»ó ÀÓ»ó2»ó ÀÓ»ó3/4»ó ½ÃÆÇ
½ÉÇ÷°ü°è Áúȯ

SP-8416

½ÉºÎÀü

»êÇп¬

SP-8356

ÇãÇ÷¼º ³úÁ¹Áß, µ¿¸Æ°æÈ­Áõ

»êÇп¬, »êÀںΠÀ¯¸Á¹ÙÀÌ¿À IPÃËÁø

Otaplimastat
(SP-8203)

ÇãÇ÷¼º ³úÁ¹Áß

º¹ÁöºÎ 10´ë Ưȭ, ÀÚü°³¹ß

Ä­µ¥¾Ï·Î¢ç

°íÇ÷¾Ð

2Á¦ º¹ÇÕÁ¦, ÀÚü°³¹ß

Otaplimastat
ALS

Ãß°¡ ÀûÀÀÁõ

Ä­µ¥¾Ï·Î
Ç÷¯½º¢â

°íÇ÷¾Ð

3Á¦ º¹ÇÕÁ¦, ÀÚü°³¹ß

¿¡Á¦·Î¼ö¢ç

°íÁöÇ÷Áõ

2Á¦ º¹ÇÕÁ¦, ÀÚü°³¹ß

SP-8257

³­Ä¡¼º ½É³úÇ÷°ü Áúȯ

°ñÁúȯ

ÇÏÀ̾ËÇ÷º½º¢ç

°ñ°üÀý¿°

»êÀںΠATC/¿ùµåŬ·¡½º Ç÷¯½º

ÇÏÀ̾Ëž¢ç

°ñ°üÀý¿°

»êÀںΠ¿ùµåŬ·¡½º Ç÷¯½º

ÀÇ·á±â±â

SP5V005

¼ö¼ú ½Ã À¯Âø¹æÁö, Ãß°¡ ±â´É

ÀÚü°³¹ß

¸ÞµðĿư¢ç

¼ö¼ú ½Ã À¯Âø¹æÁö

ÀÚü°³¹ß

°¨¿°¼º Áúȯ

ÇÇ¶ó¸Æ½º¢ç Á¤

COVID-19

¾à¹°ÀçâÃâ, ÀÚü°³¹ß

ÇÇ¶ó¸Æ½º¢ç Á¤

¸»¶ó¸®¾Æ

º¹ÇÕÁ¦, ¼ºÀοë, ÀÚü°³¹ß, WHO-MMV

ÇÇ¶ó¸Æ½º¢ç °ú¸³

¸»¶ó¸®¾Æ

º¹ÇÕÁ¦, ¼Ò¾Æ¿ë, ÀÚü°³¹ß, WHO-MMV

Ç÷§Æû±â¼ú °³¹ßÁøÀÔ

Ư¼ö Á¦Çü

¼­¹æÈ­, Àú·ùÇü, Double layer formulation, Tablet in Capsule, etc.